Dong-You Zheng1, Juan Zhao2, Jie-Mei Yang3, Miao Wang4, Xing-Tong Zhang4. 1. Department of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150086, PR China. 2. Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, PR China. Electronic address: hrbzyz@sina.com. 3. Department of Cardiology Ultrasound, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, PR China. 4. Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, PR China.
Abstract
AIM: This study aimed to investigate the dynamic expression of A-disintegrin-and-metalloproteinase-17 (ADAM17) during cardiac remodeling after acute myocardial infarction (AMI). MAIN METHODS: Forty male Wistar rats with a permanent ligation of the left anterior descending artery were equally divided into four groups based on predefined sacrifice time: MI1d, MI1w, MI4w and MI12w. As controls, 36 rats only with left thoracotomy were equally divided into four groups. Cardiac remodeling was assessed by echocardiography and hematoxylin and eosin (H&E) staining. ADAM17 mRNA was detected by real-time reverse transcription polymerase chain reaction, and protein expression of ADAM17, tissue inhibitor of metalloproteinases-3 (TIMP-3) and TNF-α was analyzed by western blotting. KEY FINDINGS: The systolic function was sharply worsened in the MI1w group (versus the Con1w group, P<0.05), but left ventricular weight index was significantly increased after 4weeks post-MI (P<0.05). H&E staining revealed that one week after AMI, myocardial tissue in the epicardial border zone of the infarcted heart was mixed with broken mitochondrial cristae and decreased matrix density. ADAM17 mRNA and protein expression was significantly increased, accompanied by decreased TIMP-3 and upregulated TNF-α expression in the MI1w group (versus the MI1d group, all P<0.05). Moreover, dynamic ADAM17 mRNA expression was positively correlated with enlarged LVEDd and LVESd (P=0.001, P=0.003) and negatively with LVEF (P=0.039) in AMI rats. SIGNIFICANCE: Enhanced ADAM17 expression, along with decreased TIMP-3 and increased TNF-α expression, especially within one week after AMI, is associated with cardiac remodeling.
AIM: This study aimed to investigate the dynamic expression of A-disintegrin-and-metalloproteinase-17 (ADAM17) during cardiac remodeling after acute myocardial infarction (AMI). MAIN METHODS: Forty male Wistar rats with a permanent ligation of the left anterior descending artery were equally divided into four groups based on predefined sacrifice time: MI1d, MI1w, MI4w and MI12w. As controls, 36 rats only with left thoracotomy were equally divided into four groups. Cardiac remodeling was assessed by echocardiography and hematoxylin and eosin (H&E) staining. ADAM17 mRNA was detected by real-time reverse transcription polymerase chain reaction, and protein expression of ADAM17, tissue inhibitor of metalloproteinases-3 (TIMP-3) and TNF-α was analyzed by western blotting. KEY FINDINGS: The systolic function was sharply worsened in the MI1w group (versus the Con1w group, P<0.05), but left ventricular weight index was significantly increased after 4weeks post-MI (P<0.05). H&E staining revealed that one week after AMI, myocardial tissue in the epicardial border zone of the infarcted heart was mixed with broken mitochondrial cristae and decreased matrix density. ADAM17 mRNA and protein expression was significantly increased, accompanied by decreased TIMP-3 and upregulated TNF-α expression in the MI1w group (versus the MI1d group, all P<0.05). Moreover, dynamic ADAM17 mRNA expression was positively correlated with enlarged LVEDd and LVESd (P=0.001, P=0.003) and negatively with LVEF (P=0.039) in AMI rats. SIGNIFICANCE: Enhanced ADAM17 expression, along with decreased TIMP-3 and increased TNF-α expression, especially within one week after AMI, is associated with cardiac remodeling.
Keywords:
A disintegrin and metalloproteinase-17; Left ventricle; Myocardial infarction; Myocardial remodeling; Tissue inhibitor of metalloproteinase-3; Tumor necrosis factor-α
Authors: Jiaxi Xu; Snigdha Mukerjee; Cristiane R A Silva-Alves; Alynne Carvalho-Galvão; Josiane C Cruz; Camille M Balarini; Valdir A Braga; Eric Lazartigues; Maria S França-Silva Journal: Front Physiol Date: 2016-10-18 Impact factor: 4.566
Authors: Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas Journal: Int J Mol Sci Date: 2021-11-26 Impact factor: 5.923